Application Nr Approved Date Route Status External Links
ANDA205520 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage 1.1 Supraventricular Tachycardia Or Noncompensatory Sinus Tachycardia Esmolol Hydrochloride Injection Is Indicated For The Rapid Control Of Ventricular Rate In Patients With Atrial Fibrillation Or Atrial Flutter In Perioperative, Postoperative, Or Other Emergent Circumstances Where Short Term Control Of Ventricular Rate With A Short-Acting Agent Is Desirable. Esmolol Hydrochloride Injection Is Also Indicated In Noncompensatory Sinus Tachycardia Where, In The Physician’s Judgment, The Rapid Heart Rate Requires Specific Intervention. Esmolol Hydrochloride Injection Is Intended For Short-Term Use. 1.2 Intraoperative And Postoperative Tachycardia And Hypertension Esmolol Hydrochloride Injection Is Indicated For The Short-Term Treatment Of Tachycardia And Hypertension That Occur During Induction And Tracheal Intubation, During Surgery, On Emergence From Anesthesia And In The Postoperative Period, When In The Physician’s Judgment Such Specific Intervention Is Considered Indicated. Use Of Esmolol Hydrochloride Injection To Prevent Such Events Is Not Recommended. Esmolol Hydrochloride Injection Is A Beta Adrenergic Blocker Indicated For The Short-Term Treatment Of: Control Of Ventricular Rate In Supraventricular Tachycardia Including Atrial Fibrillation And Atrial Flutter And Control Of Heart Rate In Noncompensatory Sinus Tachycardia (1.1) Control Of Perioperative Tachycardia And Hypertension (1.2)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Esmolol Hydrochloride ESMOLOL HYDROCHLORIDE ZINC896523

Comments